University of Saskatchewan
Saskatoon, Saskatchewan, S7N 5B2, Canada
NCT Number: NCT02529917
Forty physically active men and women aged 18-45y will take part in an 8-week resistance training program, randomized (double blind) 1:1 into each of two groups. Twenty participants will be randomized to receive 60 g/d of hemp powder (containing approximately 40 g protein and 9 g oil) supplementation and 20 randomized to receive 60 g/d of soy supplementation (matched to the hemp for macronutrients and calories) during eight weeks of training. Each participant will complete testing before and after the intervention for assessment of body composition (lean tissue, fat, and bone mass), strength, central fatigue, markers of inflammation, and bone resorption. Over the 8-weeks of training, participants will train four-five days per week for 1-1.5 hours per session with exercises targeting all major muscle groups. The training will involve a "two day split" where different muscle groups are trained on two consecutive days (day 1 involves chest, back, and arms; day 2 legs, shoulders, and abdominals). Resistance training will provide the necessary stimulus for protein synthesis to optimize the effect of a protein-containing nutritional supplement. The hemp or soy powder will be consumed in two doses (i.e. 30 g powder containing 20 g protein per dose) immediately after exercise sessions and one hour after exercise. This dosing regimen is optimal for stimulating muscle protein synthesis and building muscle mass . On the one non-training day per week the two doses will be consumed with meals.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Saskatoon, Saskatchewan, S7N 5B2, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hemp powder supplement
Soy powder supplement
Time frame: 8 weeks
Lean tissue mass measured with dual energy x-ray absrorptiometry
Time frame: 8 weeks
Fat mass as measured by dual energy x-ray absorptiometry
Time frame: 8 weeks
Bone mass as measured by dual energy x-ray absorptiometry
Time frame: 8 weeks
Muscle thickness as assessed by ultrasound
Time frame: 8 weeks
muscle thickness as measured by ultrasound
Time frame: 8 weeks
Bench press strength as assess on a plate-loaded machine by the 1-RM method
Time frame: 8 weeks
Arm curl strength as assessed with dumbbells by the 1-RM method
Time frame: 8 weeks
Leg press strength as assessed on a leg-press machine by the 1-RM method
Time frame: 8 weeks
Interleukin-6 levels measured from saliva samples
Time frame: 8 weeks
C-reactive protein levels measured from saliva samples
Time frame: 8 weeks
N-telopeptides measured from urine samples
Time frame: 8 weeks
Voluntary muscle activation as measured by the interpolated twitch technique
University of Saskatchewan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07580144
Atrophy, Frailty
Konya, Turkey (Türkiye)
View Trial DetailsNCT06629805
Atrophy, Muscular Atrophy
Yangsan, South Korea
View Trial DetailsNCT07629063
Atrophy, Basal Ganglia Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07716839
Aging, Atrophy
Montes Claros, Minas Gerais, Brazil
View Trial Details